Fiedorek Fred T. 4
4 · Verve Therapeutics, Inc. · Filed Sep 19, 2023
Insider Transaction Report
Form 4
Fiedorek Fred T.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-09-18+180,000→ 180,000 totalExercise: $12.71Exp: 2033-09-17→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option was granted on September 18, 2023. 25% of the shares underlying the option will vest on September 18, 2024, and the remainder are scheduled to vest in equal monthly installments thereafter until September 18, 2027.